Published in Crit Rev Immunol on January 01, 1986
Tumorigenesis mediated by an antigen receptor. Proc Natl Acad Sci U S A (1992) 0.85
CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 12.24
Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol (1992) 3.39
A simple, rapid method for the purification of poly A+ RNA. Biotechniques (1988) 3.22
Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology (1996) 2.01
Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol (2001) 1.85
The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol Rev (1986) 1.81
Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas. J Immunol (1988) 1.72
Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. J Biol Chem (2000) 1.70
Variation of antigenic characteristics between different mouse lymphomas induced by the Moloney virus. J Natl Cancer Inst (1966) 1.61
A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation (2001) 1.61
Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet (1984) 1.57
Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection. Eur J Immunol (1989) 1.52
Cord blood mononuclear cell cytokine responses in relation to maternal house dust mite allergen exposure. Clin Exp Allergy (2002) 1.51
Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J Virol (1997) 1.50
Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity. J Immunol (1983) 1.49
Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med (2001) 1.48
Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen. Proc Natl Acad Sci U S A (1986) 1.46
Phosphatidyl choline is recognized by a series of Ly-1+ murine B cell lymphomas specific for erythrocyte membranes. J Exp Med (1986) 1.43
High frequency expression of S107 VH genes by peritoneal B cells of B10.H-2aH-4bP/WTS mice. J Immunol (1990) 1.43
Dextran sulphate: an adjuvant for cell-mediated immune responses. Immunology (1977) 1.33
B-1 cells are made, not born. Immunol Today (1993) 1.32
Novel type of murine B-cell lymphoma. Nature (1978) 1.29
Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity. J Exp Med (1983) 1.27
Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells. Eur J Immunol (1999) 1.25
Automobile emissions are statistically gamma distributed. Environ Sci Technol (1994) 1.24
Transplantable B-cell lymphomas in B10. H-2aH-4bp/Wts mice. Immunogenetics (1982) 1.23
Cytolysis of mouse lymph node cells by alloantibody: a comparison of guinea-pig and rabbit complements. Immunology (1969) 1.22
Restricted immunoglobulin variable region gene usage by normal Ly-1 (CD5+) B cells that recognize phosphatidyl choline. J Exp Med (1989) 1.20
Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology (1996) 1.19
Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res (1997) 1.19
False detection of negative-strand hepatitis C virus RNA. Lancet (1994) 1.18
Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. J Immunol (1997) 1.17
Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins. J Virol (1986) 1.16
Different CD40-mediated signaling events require distinct CD40 structural features. J Immunol (1996) 1.15
Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation. J Immunol (1999) 1.15
Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. J Immunol (1984) 1.11
On-road vehicle emissions: regulations, costs, and benefits. Science (1995) 1.11
Antigen-induced murine B cell lymphomas. I. Induction and characterization of CH1 and CH2. J Immunol (1978) 1.11
Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev (2000) 1.11
Oxygen binding constants for human hemoglobin tetramers. Biochemistry (1987) 1.09
The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes. J Immunol (1999) 1.08
Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation (1993) 1.08
B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation. J Exp Med (1998) 1.06
Cytokine profiles in spontaneously regressing basal cell carcinomas. Br J Dermatol (2000) 1.05
Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions. J Immunol (2000) 1.05
Medium spiny neuron projection from the rat striatum: an intracellular horseradish peroxidase study. Brain Res (1980) 1.04
Role of interferon in human natural killer activity against target cells infected with HSV-1. J Immunol (1983) 1.04
Phenotype of B cells responding to the thymus-independent type-2 antigen polyvinyl pyrrolidinone. Int Immunol (1996) 1.02
Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. Gastroenterology (1994) 1.02
Production, testing, and utility of double congenic strains of mice.I. B10 H-2aa=H-48P-wis and Bio-H-4BP-Wis. Transplantation (1974) 1.02
Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers. Kidney Int (1986) 1.01
Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats. J Pharmacol Exp Ther (1996) 1.01
Physiological and anatomical studies of the interactions between Purkinje cells and basket cells in the cat's cerebellar cortex: evidence for a unitary relationship. J Neurosci (1989) 1.01
Cross-reactive idiotypes and common antigen binding specificities expressed by a series of murine B-cell lymphomas: etiological implications. Proc Natl Acad Sci U S A (1985) 1.01
The murine kappa light chain shift. Nature (1978) 1.01
Sentinel skin allograft-a reliable marker for monitoring of composite tissue transplant rejection. Transplant Proc (2009) 1.00
Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation (1995) 1.00
Naturally occurring soluble H-2 specificity in mouse tissues. Immunology (1965) 1.00
T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas. J Invest Dermatol (1997) 0.99
Two separate functions of class II (Ia) molecules: T-cell stimulation and B-cell excitation. Proc Natl Acad Sci U S A (1985) 0.99
CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. J Immunol (1996) 0.99
Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology (1997) 0.98
Transplantation antigen of mice: cellular localization of antigen determined by the H-2 locus. Transplantation (1966) 0.98
Morphological and physiological properties of neostriatal neurons: an intracellular horseradish peroxidase study in the rat. Neuroscience (1982) 0.97
Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation (1999) 0.97
Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen. J Immunol (1978) 0.97
Antigenic cross-reactivity between adenocarcinoma of the breast and fibrocystic disease of the breast. J Natl Cancer Inst (1976) 0.97
The male antigen. II. Regulation of the primary and secondary responses to H-Y by H-2 associated genes. Cell Immunol (1974) 0.97
The distribution and origin of serotonin immunoreactivity in the rat cerebellum. Brain Res (1985) 0.96
Requirement for nuclear factor-kappaB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J Immunol (1999) 0.95
Early up-regulation of macrophages and myofibroblasts: a new marker for development of chronic renal allograft rejection. Transplantation (2000) 0.95
H-2 control of expression of an idiotype shared by normal B cells and a B-cell lymphoma. Immunogenetics (1985) 0.94
Suppression or augmentation of the antihapten response in mice by antibodies of different specificities. J Exp Med (1973) 0.94
Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats. J Pharmacol Exp Ther (1994) 0.93
The use of electron microscopic immunocytochemistry with silver-enhanced 1.4-nm gold particles to localize GAD in the cerebellar nuclei. J Histochem Cytochem (1995) 0.93
Specific immunosuppression by minute doses of passive antibody. II. The site of action. J Reticuloendothel Soc (1970) 0.93
Morphological and electrophysiological characteristics of projection neurons in the nucleus interpositus of the cat cerebellum. J Comp Neurol (1978) 0.92
Role of cell surface immunoglobulin in B-lymphocyte activation. Proc Natl Acad Sci U S A (1984) 0.92
Induced differentiation of a B cell lymphoma with known antigen specificity. J Mol Cell Immunol (1984) 0.92
A VH12 transgenic mouse exhibits defects in pre-B cell development and is unable to make IgM+ B cells. J Immunol (2001) 0.91
Immunosuppression by antilymphocyte serum and its effect on tumors indduced by 3-methylcholanthrene in mice. J Natl Cancer Inst (1971) 0.91
Allele non-amplification: a source of confusion in linkage studies employing microsatellite polymorphisms. Hum Mol Genet (1993) 0.91